ASX:FTT

Factor Therapeutics Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume425,600 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive FTT News and Ratings via Email

Sign-up to receive the latest news and ratings for Factor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

About Factor Therapeutics

Factor Therapeutics Limited operates as a biotechnology company that focuses on developing and commercializing advanced wound care therapies. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited was incorporated in 2002 and is based in Brisbane, Australia.

Anatara Lifesciences Limited (ANR.AX) Chair Transition
July 25, 2021 | au.finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:FTT
Previous Symbol: ASX:TIS
CUSIP: N/A
CIK: N/A
Web: factor-therapeutics.com
Phone: +61-7-33343900
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $1,794.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 1.00
Book Value: A$0.03 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 19.84
Quick Ratio: 19.76

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Factor Therapeutics.

4.7 Community Rank

Outperform Votes
Factor Therapeutics has received 84 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Factor Therapeutics has received 36 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Factor Therapeutics has received 70.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Factor Therapeutics and other stocks. Vote “Outperform” if you believe FTT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FTT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Factor Therapeutics does not currently pay a dividend.
Dividend Growth
Factor Therapeutics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Factor Therapeutics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Factor Therapeutics (ASX:FTT) Frequently Asked Questions

What stocks does MarketBeat like better than Factor Therapeutics?: Wall Street analysts have given Factor Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Factor Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How were Factor Therapeutics' earnings last quarter?: Factor Therapeutics Limited (ASX:FTT) posted its quarterly earnings data on Thursday, August, 8th. The biotechnology company reported $0.00 EPS for the quarter.
View Factor Therapeutics' earnings history.
Who are Factor Therapeutics' key executives?: Factor Therapeutics' management team includes the following people:
Ms. Melanie Farris M.A.I.C.D., ACIS) BComn, (AGIA, GradDip, ACG, Company Sec. & Non-Exec. Director
Who are some of Factor Therapeutics' key competitors?: Some companies that are related to Factor Therapeutics include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).
View all of FTT's competitors.
What is Factor Therapeutics' stock symbol?: Factor Therapeutics trades on the ASX under the ticker symbol "FTT."
How much money does Factor Therapeutics make?: Factor Therapeutics has a market capitalization of $0.00 and generates $1,794.00 in revenue each year.
What is Factor Therapeutics' official website?: The official website for Factor Therapeutics is factor-therapeutics.com.
Where are Factor Therapeutics' headquarters?: Factor Therapeutics is headquartered at L 19 179 Turbot St, BRISBANE, QLD 4000, Australia.
How can I contact Factor Therapeutics?: Factor Therapeutics' mailing address is L 19 179 Turbot St, BRISBANE, QLD 4000, Australia. The biotechnology company can be reached via phone at +61-7-33343900.

This page was last updated on 10/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.